LMAT vs. UTHR
Compare and contrast key facts about LeMaitre Vascular, Inc. (LMAT) and United Therapeutics Corporation (UTHR).
Performance
LMAT vs. UTHR - Performance Comparison
Loading graphics...
LMAT vs. UTHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LMAT LeMaitre Vascular, Inc. | 34.92% | -10.95% | 63.63% | 24.60% | -7.40% | 25.10% | 14.09% | 53.77% | -25.13% | 26.58% |
UTHR United Therapeutics Corporation | 21.70% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
Fundamentals
LMAT:
$2.51B
UTHR:
$28.40B
LMAT:
$2.47
UTHR:
$27.90
LMAT:
44.28
UTHR:
21.25
LMAT:
1.91
UTHR:
0.70
LMAT:
10.24
UTHR:
8.91
LMAT:
6.37
UTHR:
4.00
LMAT:
$249.60M
UTHR:
$3.18B
LMAT:
$178.54M
UTHR:
$2.80B
LMAT:
$85.42M
UTHR:
$1.82B
Returns By Period
In the year-to-date period, LMAT achieves a 34.92% return, which is significantly higher than UTHR's 21.70% return. Over the past 10 years, LMAT has outperformed UTHR with an annualized return of 22.62%, while UTHR has yielded a comparatively lower 18.04% annualized return.
LMAT
- 1D
- 2.15%
- 1M
- 1.15%
- YTD
- 34.92%
- 6M
- 25.33%
- 1Y
- 31.31%
- 3Y*
- 29.74%
- 5Y*
- 18.74%
- 10Y*
- 22.62%
UTHR
- 1D
- 0.79%
- 1M
- 17.68%
- YTD
- 21.70%
- 6M
- 41.45%
- 1Y
- 92.36%
- 3Y*
- 38.34%
- 5Y*
- 25.25%
- 10Y*
- 18.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LMAT vs. UTHR — Risk / Return Rank
LMAT
UTHR
LMAT vs. UTHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for LeMaitre Vascular, Inc. (LMAT) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LMAT | UTHR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.80 | 1.84 | -1.04 |
Sortino ratioReturn per unit of downside risk | 1.55 | 3.30 | -1.74 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.46 | -0.25 |
Calmar ratioReturn relative to maximum drawdown | 1.66 | 5.70 | -4.04 |
Martin ratioReturn relative to average drawdown | 3.00 | 14.49 | -11.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LMAT | UTHR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.80 | 1.84 | -1.04 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.52 | 0.72 | -0.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | 0.51 | +0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | 0.39 | -0.03 |
Correlation
The correlation between LMAT and UTHR is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
LMAT vs. UTHR - Dividend Comparison
LMAT's dividend yield for the trailing twelve months is around 0.78%, while UTHR has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LMAT LeMaitre Vascular, Inc. | 0.78% | 1.23% | 0.69% | 0.99% | 1.09% | 0.88% | 0.94% | 0.95% | 1.18% | 0.69% | 0.71% | 0.93% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
LMAT vs. UTHR - Drawdown Comparison
The maximum LMAT drawdown since its inception was -75.69%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for LMAT and UTHR.
Loading graphics...
Drawdown Indicators
| LMAT | UTHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.69% | -93.18% | +17.49% |
Max Drawdown (1Y)Largest decline over 1 year | -19.91% | -16.35% | -3.56% |
Max Drawdown (5Y)Largest decline over 5 years | -37.93% | -33.00% | -4.93% |
Max Drawdown (10Y)Largest decline over 10 years | -47.65% | -55.56% | +7.91% |
Current DrawdownCurrent decline from peak | -3.75% | 0.00% | -3.75% |
Average DrawdownAverage peak-to-trough decline | -19.04% | -35.53% | +16.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.01% | 6.43% | +4.58% |
Volatility
LMAT vs. UTHR - Volatility Comparison
The current volatility for LeMaitre Vascular, Inc. (LMAT) is 7.72%, while United Therapeutics Corporation (UTHR) has a volatility of 17.05%. This indicates that LMAT experiences smaller price fluctuations and is considered to be less risky than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LMAT | UTHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.72% | 17.05% | -9.33% |
Volatility (6M)Calculated over the trailing 6-month period | 27.47% | 26.84% | +0.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.28% | 50.41% | -11.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.27% | 35.89% | +0.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.51% | 35.32% | +6.19% |
Financials
LMAT vs. UTHR - Financials Comparison
This section allows you to compare key financial metrics between LeMaitre Vascular, Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LMAT vs. UTHR - Profitability Comparison
LMAT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, LeMaitre Vascular, Inc. reported a gross profit of 46.19M and revenue of 64.45M. Therefore, the gross margin over that period was 71.7%.
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported a gross profit of 686.80M and revenue of 790.20M. Therefore, the gross margin over that period was 86.9%.
LMAT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, LeMaitre Vascular, Inc. reported an operating income of 18.83M and revenue of 64.45M, resulting in an operating margin of 29.2%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported an operating income of 356.70M and revenue of 790.20M, resulting in an operating margin of 45.1%.
LMAT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, LeMaitre Vascular, Inc. reported a net income of 15.58M and revenue of 64.45M, resulting in a net margin of 24.2%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, United Therapeutics Corporation reported a net income of 364.30M and revenue of 790.20M, resulting in a net margin of 46.1%.